Medical-grade sensors, 95% tracking accuracy, and 6-day battery life make this ultra-light smart ring the most compelling ...

The objective response rate for LM was 51.6%, including a 15.6% complete response, and the disease control rate was 81.3% by BICR in the LM efficacy evaluable ... supporting its effective CNS ...

The second phase of a large-scale demolition drive targeting illegal encroachments near Ahmedabad’s Chandola Lake began Tuesday morning. It is aimed at clearing an estimated 2.5 lakh square meters of ...

This paper shows that the variable frequency drive incorporated in a rotating shaft is one of the main root causes of mechanical-shaft failures. Simple analytical relationships show that the ...

The levy currently stands at 3 per cent to 7.5 per cent. "The situation is full of uncertainties and it is a big risk to launch a policy that will impact competitiveness of Indonesia's palm oil ...

For the constant power control of the CCPS, variable frequency modulation works in a wide frequency range with large reactive power, and phase-shift modulation (PSM) cannot work with a wide gain range ...

The third phase of the Ireland Road-Ironwood Drive construction project begins Friday, May 9, in South Bend. The work will focus on the center lanes and the Ironwood Drive intersection for the ...

CLARKSBURG, W.Va. (WBOY) — Three men have been charged after allegedly using an AK-47 to kidnap a victim and force him to drive to a residence in Clarksburg. According to a criminal complaint filed by ...

The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

“This is where their dreams will take shape,” said Governing Board President Kristen Acton at the groundbreaking ceremony. “As a governing board, we are beyond excited. I had a hard time with that ...

At 3 months after infusion ... These patients have limited treatment options and poor prognoses. 10,11 This phase 1 trial of huCART19-IL18 involving patients with CD19+ B-cell lymphomas was ...